Researchers developed a nasal antibody that blocks mugwort pollen, a major hay fever trigger in Europe and Central Asia.

Discover how Agilent's AssayMAP Bravo and RapidFire systems accelerate drug discovery with automation and rapid, reliable ...

At ASMS 2025, the Technology Networks team spoke with Chris Lock from SCIEX to discuss how improvements in proteomics ...

University of Queensland researchers developed a custom tool combining ultrasound and imaging to observe how brain cells ...

Researchers have identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in ...

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate ...

Scientists have discovered novel drug candidates that could ultimately lead to new effective treatments for conditions caused ...

How concerned should we be about PFAS in our drinking water? Professor Rainer Lohmann answers this question and more.

Women diagnosed with premenstrual symptoms have a slightly increased risk of developing cardiovascular disease later in life.

The FDA has released 200+ complete response letters in a bid to offer new insights into drug approval rejections and ...

Scientists have produced a new roadmap outlining how genetic changes can affect the oil production of plants commonly used to ...

The results offer real-world data that support long-term protection through vaccination and suggest a level of population ...